Alvaro JD., Tatro JB., Duman RS. Minireview : melanocortins and opiate addiction. Life Sci. 1997; 61: 1- 9.
Bai FL., Yamano M., Shiotani Y., Emson PC., Smith AD., Powell JF., Tahyama M. An arcuato-paraventricular and dorsomedial
hypothalamic neuropeptide Y-containing system which lacks noradrenalin in the rat. Brain Res 1985; 331:172-5.
Baskin DG., Breininger JF., Schwartz MW. Leptin receptor mRNA
identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 1999; 48: 828-33.
Baskin DG., Norwood BJ., Schwartz MW., Koerker DJ. Estrogen inhibits the increase of hypothalamic neuropeptide Y messenerger ribonucleic acid expression induce by weight loss in ovariectomized. Endocrinology.
1995; 12:5547-54.
Billington CJ., Briggs JE., Grace M., Levine AS. Effects of intracerebrovennricular injection of neuropeptide Y on energy metabolism. Am J Physiol. 1991; 260:R321-7.
Billington CJ., Briggs JE., Harker S., Grace M., Levine AS., Neuropeptide Y in hypothalamic paraventricular nucleus : A center coordinating energy metabolism. Am J Physiol. 1994; 266 : R1765-70.
Bonavera JJ., Dube MG., Kalra PS., Kalra SP. Anorectic effects of estrogen may be mediated by decreased neuropeptide- Y release in the hypothalamic paraventricular nucleus. Endocrinology, 1994; 134:
2367-70.
Cagnacci A., Soldani R., Carriero PL., Paoletti AM., Fioretti P., Melis GB. Effects of low doses of transdermal 17 beta-estradiol on
carbohydrate metabolism in postmenopausal women. J Clin Endocrinol.
1992; l74: 1396-400.
Chance WT., Balasubramaniam A., Dayal R. Hypothalamic concentration and release of neuropeptide Y into the microdialysates is reduced in
anorectic tumor –bearing rats. Life Sci. 1994; 54: 1869-74.
Clark JT., Kalra PS., Crowley WR., Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 1984; 115: 427-9.
Clark JT., Kalra PS., Crowley WR., Kalra SP. Neuropeptide Y
stimulates feeding, but inhibits sexual behavior in rats. Endocrinology 1985; 117: 2435-42.
Clark JT., Sahu A., Kalra PS., Balasubramaniam A., Kalra SP.
Neuropeptide Y-induced feeding behavior in female rats: comparison with human YY. Regu Pept. 1987; 17: 31-9.
Dagnault A., Richard D. Lesions of hypothalamic paraventricular nuclei do not prevent the effect of estradiol on energy and fat balance. Am J Physiol Endocrinol Metab 1994; 267: E32-E38.
Dube MG., Kalra PS., Crowley WR., Kalra SP. Evidence of physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res. 1991; 690: R328-34.
Eckel LA., Geary N. Estradiol treatment increases feeding-induced c-Fos expression in the brains of ovariectomized rats. Am J Physiol, 2001; 281:
R738-46.
Eckel LA.,, Houpt TA., Geary N. Estradiol treatment increases
CCK-induced c-Fos expression in the brains of ovariectomized rats. Am J Physiol. 2002; 283: R1378-85.
Egawa M., Yoshimatsu H., Bray G. Neuropeptide Y suppresses
sympathetic activity to interscapular brown adipose tissue in rats. Am J Physiol. 1991; 260:R328-34.
Everitt BJ., Hakfelt T. The coexistence of neuropeptide Y with other peptides and amines in the central nervous system. In: Mutt
V, Fiixe K, HBkfelt T, Lundberg J (eds) Neuropeptide Y. Raven Press, New York, 1989; pp 61-72.
Fan W., Boston BA., Kesterson RA., Hruby VJ., Cone RD. Role of melanocortinergic neurons in feeding and the Agouti obesity syndrome.
Nature. 1997; 385:165-8.
Geary N. The Effect of Estrogen on Appetite. Medscape Women Healthy.
1998; 3:3.
Geary N. Estradiol, CCK and satiation. Peptides. 2001; 22: 1251-63.
Geary N., Asarian L. Estradiol increases glucagon's satiating potency in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol, 2001; 281:
R1290-94.
Geary N., Asarian L., Korach KS., Pfaff DW., Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology. 2001; 11: 4751-57.
Grill HJ., Ginsberg AB., Seeley RJ., Kaplan JM. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. Neurosci. 1998; 18: 10128-35.
Gustafsson JÅ. Estrogen receptor ß - a new dimension in estrogen mechanism of action" J Endocrinol 1999; 163: 379-83.
Heine P. A., Jensen D.R., Taylor J.A., Lubahn D.B., Eckel R.H.,
Cooke P.S., Estrogen receptor alpha (ERa) regulates the effect of estrogen
on metabolic rate (MR).The Endocrine Society Research Summaries Book.
2001; P3-110, (Abstract).
Inui A. Transgenic approach to the study of body weight regulation.
Pharmacol Rev., 2000; 52: 35-55.
Ishihara A., Tanaka T., Kanatani A., Fukami T., Ihara M., Fukuroda T. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol. 1998; 274:R1500-4.
Kalra SP., Bube MG., Pu S., Xu B., Horvath TH., Karlra SP. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 1999; 20: 68-100.
Kanatani A., Ishihara A., Aahi S., Tanaka T., Ozaki S., Ihara M. A potent neuropeptide Y Y1 receptor antagonist, 1229U91 :blockade of
neuropeptide Y-induced and physiological food intake. Endocrinology.
1996; 137: 3177-82.
Kask A., Rgo L., Phkla R., Wikber JES., Schioth HB. Selective
antagonist for the melanocortin 4 receptor (HS014) increase food intake in free-feeding rats. Biochem Biophys Res Commun. 1998; 245; 90-3.
Koegler FH., Grove KL., Schiffmacher A., Smith MS., Cameron JL.
Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology. 2001; 142: 2586-92.
Kraichely DM., Sun J., Katzenellenbogen JA., Katzenellenbogen BS.
Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology 2000; 141:3534-45.
Kuiper GGJM., Enmare E., Markku PH., NilssonS., Gustafsson JA.
Cloning of a novel estrogen receptor expressed in rat prostate and ovary.
Biochemistry1996; 93: 5925-30.
Lazzarini SJ., Wade GN. Role of sympathetic nerves in effects of
estradiol on rat white adipose tissue. Am J Physiol. 1991; 260: R47-R51.
Liang Y.Q., Akishita M., Kim S., Ako J., Hashimoto M., Iijima K., Ohike Y., Watanabe T., Sudoh N., Toba K., Yoshizumi M. and Ouchi Y.1 Estrogen receptor ß is involved in the anorectic action of estrogen . Int J Obes. 2002; 26: 1103?-98.
Meyers MJ., Sun J., Carlson KE., Marriner JA., Katzenellbogen BS., Katzenellbogen JA. Estrogen receptor-ß potency-selective ligands:
structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem. 2001; 44: 4230-51.
Michel M., Beck-Sickinger A., Cox H., Doods HN., Herzog H., Larhammar D., Quiroon R., Schwartz T. Westfall T. International of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;
50: 143-9.
Moras D., Gronemeyer H. The nuclear receptor ligand-binding domain:
structure and function. Curr Opin Cell Biol. 1998; 10: 384-91.
Morrell JI., Krieger MS., Pfaff DW. Quantitative autoradiographic analysis of estradiol retention by cells in the preoptic area,
hypothalamic and amygdala. Exp Brain kes. 1986; 62: 343-54 a.
Mountjoy KG., Mortrud MT., Low MJ., Simerly RB., Cone RD.
Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. J Endocrinol. 1994; 8:
1298-308.
Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd Ed.
Academic Press Inc; 1986.
Pelletier G. Regulation of proopiomelanocortin gene expression in rat brain and pituitary as studied by in situ hybridization. Ann N Y Acad Sci.
1993; 680: 246-259.
Pettersson K., Gustafsson JÅ. Role of estrogen receptor beta in estrogen action. Ann Rev Physiol. 2001; 63: 165-92.
Polidori C., Ciccocioppo R., Regoli D., Massi M. Neuropeptide Y
receptors mediating feeding in the rat : characterization with antagonists.
Peptides. 2000; 21: 29-35.
Roesch D. Estrogen receptor alpha, not beta, is the primary mediator of the attenuating effects of estrogens on body weight gain. Annual Meeting of Society for the Study of Ingestive Behavior. 2004, (Abstract).
Sahu A., Crowley WR., Kalra SP. Hypothalamic neuropeptide- Y gene expression increases before the onset of the ovarian steroid - induced luteinizing hormone surge. Endocrinology. 1994; 134: 1018-22.
Sahu A., Kalra SP. Neuropeptidergic regulation of feeding
behavior: neuropeptide Y. Trends Endocrinol Metab. 1993; 4: 217-24.
Sahu A., Phelos CP., White ID., Crowlev WR., Kalra SP., Kalra PS.
Steroidai regulation of- hypothala& neuropeptide Y release and gene expression. Endocrinolog. 1992; 130: 3331-6.
Sar M., Sahu A., Crowley WR., Kalra SP. Localization of
neuropeptide Y (NPY) immunoreactivity in estradiol concentrating cells in the hypothalamus. Endocrinolog, 1990; 127: 2752-56.
Stauffer SR.,Coletta CJ., Tedeco R., Nishiguchi G., Carison K.,Sun J.,Katzenellebogen JA. Pyrazole ligands: structure-affinity/activity
relationships and estrogen receptor-alpha-selective agonists. J Med Chem 2000; 43: 4934.
Wallen WJ., Michael P., Belange., Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. J Nutr. 2001; 131:
2351-7.
Wilcox JN., Roberts JL. Estrogen decreases rat hypothalamic
proopiomelanocortin messenger ribonucleic acid levels. Endocrinology.
1985; 117: 2392-96.
Zarjevski N., Cusin I., Rohner-Jeanrenaud F., Jeanrenaud B. Chronic intracerebroventricular neuropeptide Y administration to normal rats
mimics hormonal and metabolic changes of obesity. Endocrinology. 1993 ; 133: 1753-8.